Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer.
about
Prognostic significance of volume-based PET parameters in cancer patients.Recent Trends in PET Image Interpretations Using Volumetric and Texture-based Quantification Methods in Nuclear Oncology.Prognostic Value of Metabolic Tumor Volume Measured by (18)F-FDG PET/CT in Locally Advanced Head and Neck Squamous Cell Carcinomas Treated by Surgery.Metabolic Tumor Volume Measured by F-18 FDG PET/CT can Further Stratify the Prognosis of Patients with Stage IV Non-Small Cell Lung Cancer.FDG PET/CT imaging of oropharyngeal squamous cell carcinoma: characteristics of human papillomavirus-positive and -negative tumorsPostradiation metabolic tumor volume predicts outcome in head-and-neck cancerMetabolic tumour volume as a prognostic factor for oral cavity squamous cell carcinoma treated with primary surgeryWhole-body total lesion glycolysis measured on fluorodeoxyglucose positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancerDynamic contrast-enhanced MR imaging predicts local control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy.Metabolic tumor volume is an independent prognostic factor in patients treated definitively for non-small-cell lung cancerVolumetric PET/CT parameters predict local response of head and neck squamous cell carcinoma to chemoradiotherapyCan FDG PET predict radiation treatment outcome in head and neck cancer? Results of a prospective study.Prognostic value of FDG PET metabolic tumor volume in human papillomavirus-positive stage III and IV oropharyngeal squamous cell carcinomaCorrelation between metabolic tumor volume and pathologic tumor volume in squamous cell carcinoma of the oral cavity.Quantitation of human papillomavirus DNA in plasma of oropharyngeal carcinoma patientsPrognostic value of volume-based positron emission tomography/computed tomography in patients with nasopharyngeal carcinoma treated with concurrent chemoradiotherapy.Superior prognostic utility of gross and metabolic tumor volume compared to standardized uptake value using PET/CT in head and neck squamous cell carcinoma patients treated with intensity-modulated radiotherapyClinical significance of metabolic tumor volume by PET/CT in stages II and III of diffuse large B cell lymphoma without extranodal site involvementPrognostic value of metabolic tumor volume and velocity in predicting head-and-neck cancer outcomes.Validation that metabolic tumor volume predicts outcome in head-and-neck cancer.Metabolic Tumour Burden Measured by 18F-FDG PET/CT Predicts Malignant Transformation in Patients with Neurofibromatosis Type-1.Metabolic tumor volume as a prognostic imaging-based biomarker for head-and-neck cancer: pilot results from Radiation Therapy Oncology Group protocol 0522.Prognostic value of volume-based (18)F-fluorodeoxyglucose PET/CT parameters in patients with clinically node-negative oral tongue squamous cell carcinoma.Quantitative and qualitative analysis of [(18)F]FDG and [(18)F]FAZA positron emission tomography of head and neck cancers and associations with HPV status and treatment outcome.FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinomaPrognostic PET 18F-FDG uptake imaging features are associated with major oncogenomic alterations in patients with resected non-small cell lung cancerOropharyngeal squamous cell carcinoma with known human papillomavirus status treated with definitive chemoradiotherapy: patterns of failure and toxicity outcomes.The relative prognostic utility of standardized uptake value, gross tumor volume, and metabolic tumor volume in oropharyngeal cancer patients treated with platinum based concurrent chemoradiation with a pre-treatment [(18)F] fluorodeoxyglucose positPrognostic Significance of Standardized Uptake Value on 18Fluorine-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Nasopharyngeal Carcinoma.Effect of different segmentation algorithms on metabolic tumor volume measured on 18F-FDG PET/CT of cervical primary squamous cell carcinomaApplication of fluorodeoxyglucose positron emission tomography in the management of head and neck cancers.Prognostic value of metabolic tumor volume as measured by fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in nasopharyngeal carcinoma.(18)F-FDG PET/CT quantification in head and neck squamous cell cancer: principles, technical issues and clinical applications.The role of PET/CT in the management of patients affected by head and neck tumors: a review of the literature.The clinical outcome correlations between radiation dose and pretreatment metabolic tumor volume for radiotherapy in head and neck cancer: A retrospective analysis.A review of the predictive role of functional imaging in patients with mucosal primary head and neck cancer treated with radiation therapy.Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist.18F-FDG PET-CT performed before and during radiation therapy of head and neck squamous cell carcinoma: Are they independent or complementary to each other?Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.Prognostic value of tumoral heterogeneity and volumetric parameters as measured by F18-FDG PET/CT in sinonasal cancer.
P2860
Q27687836-17C39985-0664-4E13-ABEE-6AC3C0B938E8Q33669828-92A72BE7-3445-46CA-A631-4E334BDB9084Q33704148-809566DA-2E12-4528-A1E1-8BE05C63C548Q33704656-56F85598-35F2-4597-A8E8-DEA4C2CB1790Q33819012-6374D339-FC38-45EE-83A8-EB3BAC8206B8Q34234294-21C06408-4B75-4330-955A-A0A4D516CA81Q34346395-7456908E-7202-4827-98A9-BCDFDA759BE9Q34468661-69E4FFCD-64D5-421E-9DE0-1E8C4DCF0C29Q34951384-C92218F2-496C-4582-82F8-D350CF63C46CQ34977651-75078EF8-B161-47ED-BBDD-50521D808CBBQ34998582-AA7BDABA-A02A-4A81-AF02-A237BC62793FQ35078927-9FD64894-D1AB-49FB-AB5E-1AD7B1454EDCQ35096212-D016CE8B-A2FF-45F5-9060-8B066ADFA95FQ35228288-011187ED-4426-44A9-8D57-3B78AA14EE25Q35670356-5C8EBCB9-1C64-4103-A5C4-0B95F437842CQ35672382-50C50086-70DA-4CA2-904A-BB1DE0A3441AQ35789209-F240FE90-47A5-49ED-BD79-E518D69B5538Q35871945-8BD29332-2984-4D6C-B026-280B544D0462Q35916248-53C110A3-D4F6-458A-A50B-064FF500CC6BQ35916573-C31160CC-9FB6-4B35-8C72-0FCE448D1143Q35961361-9B8543F6-85D5-45C4-8B9C-9FD4916DBBF4Q36355220-AA0525F1-5BCF-488F-82DF-333CC69BDDDEQ36357282-97FF4DB7-D536-44FD-9A65-3F5CAA38B5E8Q36619504-5E20F8E9-DBED-492D-B282-545F97D5A425Q36655475-83C1D02E-650A-456F-BD8F-F66232F6D910Q36681329-73B4CD91-B452-47F6-9F4D-64D0DA89185CQ37033505-840CCA94-A5F1-490B-B1C7-FFD18F126DCFQ37192658-98ADB783-AD97-4888-8D02-F5A1F3CC159AQ37649209-02EE8708-7D10-42E6-BBFD-5A316CA1E744Q37653213-3C2A39B2-AF29-4594-8B3F-3CC3D2D3B7D1Q38224477-DB9F1203-ACAA-443A-BD1C-8481FF9DF1E3Q38249891-6ECE53E6-5737-412D-8CAA-5A9CBD3E74DAQ38410245-03C5F8E1-4FFD-48C8-AA11-A94932FF2866Q38478344-A435008E-CD8A-43EF-90AC-591413926179Q38704691-30DCC22F-F67E-47DB-8B20-15DC5D74371CQ38836743-55F34F45-7AF2-4797-8EB8-D935D14626A1Q38896865-EB6F2CF4-E8EC-4CF6-9092-513F1D6BCF41Q38909224-518F0AAE-6EF8-4947-BAE7-37D0DD58E7B1Q40187157-3B453D1E-69F6-4295-9737-DDF1EF03B80CQ40539372-3030AEC7-03FB-4498-BA13-B5EA75096D84
P2860
Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer.
@en
Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer.
@nl
type
label
Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer.
@en
Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer.
@nl
prefLabel
Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer.
@en
Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer.
@nl
P2093
P2860
P1476
Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer.
@en
P2093
Billy W Loo
Brit B Turnbull
Edith J Filion
Edward E Graves
Jackie N Chu
Khoa Nguyen
Peter Maxim
Quynh-Thu Le
P2860
P304
P356
10.1016/J.IJROBP.2008.10.060
P407
P577
2009-03-14T00:00:00Z